Preparation and evaluation of fast-disintegrating effervescent tablets of glibenclamide

Drug Development and Industrial Pharmacy

Volumn 35, Issue 3, 2009, Pages 321-328

  Jacob, Shery ^a,d   Shirwaikar, Arun ^b   Nair, Anroop ^c  

^a MANIPAL UNIVERSITY   (India)

^b GULF MEDICAL UNIVERSITY   (United Arab Emirates)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d AMRL   (United States)

Author keywords

Balance test method; Effervescent stability; Fast effervescent tablet; Sensory test; Thermal stressing

Indexed keywords

BICARBONATE; CITRIC ACID; CROSCARMELLOSE SODIUM; EXCIPIENT; GLIBENCLAMIDE; GLUCOSE; MACROGOL; MACROGOL 10000; MANNITOL; MICROCRYSTALLINE CELLULOSE; POLYSORBATE 80; POTASSIUM HYDROGEN PHOSPHATE; SILICON DIOXIDE; SODIUM GLYCINE CARBONATE; SODIUM HYDROGEN CITRATE; SODIUM HYDROXIDE; STARCH; UNCLASSIFIED DRUG;

ARTICLE; DRUG ABSORPTION; DRUG COATING; DRUG FORMULATION; DRUG GRANULATION; DRUG SOLUBILITY; DRUG STABILITY; EFFERVESCENT TABLET; EVALUATION; HUMAN; MOISTURE; NORMAL HUMAN; PH; TABLET COMPRESSION;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; CITRIC ACID; DRUG STABILITY; EXCIPIENTS; GLYBURIDE; HUMANS; HUMIDITY; HYDROGEN-ION CONCENTRATION; MANNITOL; PATIENT SATISFACTION; POLYETHYLENE GLYCOLS; SODIUM BICARBONATE; SOLUBILITY; TABLETS; TRANSITION TEMPERATURE;

EID: 61649124300     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802337021     Document Type: Article

References (32)

1. Barbel, R., Gerolf, K., & Peter, C. S. (1998). Optimization of an effervescent tablet formulation containing spray dried-L-leucine and polyethylene glycol 6000 as lubricants using a central composite design. Eur. J. Pharm. Biopharm., 46, 85-94.
2. Bi, Y. X., Sunada, H., Yonezawa, Y., & Danjo, K. (1999). Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev. Ind. Pharm., 25, 571-581.
3. Bi, Y. X., Sunada, H., Yonezawa, Y., Danjo, K., Ostuka, A., & Iida, K. (1996). Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem. Pharm. Bull., 44, 2121-2127.
4. Blume, H., Ali, S. L., & Stewart, M. (1993). Pharmaceutical quality of glibenclamide products. A multinational postmarket comparative study. Drug Dev. Ind. Pharm., 19, 2713-2741.
5. Carr, R. L. (1965). Evaluating flow properties of solids. Chem. Eng. J., 72, 163-168.
6. Davis, S. N., & Granner, D. K. (1996). Insulin, oral hypoglycemic agents and the pharmacology of endocrine pancreas. In A. G. Gilman (Ed.), The pharmacological basis of therapeutics (9th ed., pp. 1487-1518). New York: McGraw-Hill.
7. Dohney, K. (1993). You really expect me to swallow those horse pills? Am. Drug., 108, 34-35.
8. El-Massik, M. A., Darwish, I. A., Hassan, E. E., & El-Khordagui, L. K. (1996). Development of a dissolution medium for glibenclamide. Int. J. Pharm., 140, 69-76.
9. Gucluyildiz, H., Banker, G. S., & Peck, G. E. (1977). Determination of porosity and pore-size distribution of aspirin tablets relevant to drug stability. J. Pharm. Sci., 66, 407-414.
10. Hausner, H. H. (1967). Friction conditions in a mass of metal powder. Int. J. Powder Metal., 3, 7-13.
11. Ishikawa, T., Watanabe, Y., Utoguchi, N., & Matsumoto, M. (1999). Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method. Chem. Pharm. Bull., 47, 1451-1454.
12. Khankari, R., Hontz, J., Chastain, S., & Katzner, L. (1999). International Patent Application No. 09/057, 84.
13. Koizumi, K.-I., Watanabe, Y., Morita, K., Utoguchi, N., & Matsumoto, M. (1997). New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int. J. Pharm., 152, 127-131.
14. Lavie, L. (1986). Effervescent mixture characterized by protracted release of gas and the use of this mixture in the preparation of carbonated drinks, US Patent No. 4579742.
15. Madan, A., Trehan, A., & Vinod Kumar, A. (2004). Process for the preparation of fast dissolving dosage form, US Patent No. 20040258748.
16. Marshall, K. (1987). In L. Lachman, H. A. Liberman, & J. I. Kanig (Eds.), The theory and practice of industrial pharmacy (3rd ed., pp. 66-99), Lea & Febiger, Philadelphia, PA, USA.
17. Mohrle, R. (1989). Effervescent tablets. In H. A. Lieberman, L. Lachman, & J. B. Schwartz (Eds.), Pharmaceutical dosage forms: Tablets (2nd ed., Vol. 1, pp. 225-258). New York: Marcel Dekker, Inc.
18. Neil, R. A., Banker, G. S., & Peck, G. E. (1982a). Quantitative evaluation of pharmaceutical effervescent systems I: Design of testing apparatus. J. Pharm. Sci., 71, 3-6.
19. Neil, R. A., Banker, G. S., & Peck, G. E. (1982b). Quantitative evaluation of pharmaceutical effervescent systems II: Stability monitoring by reactivity and porosity measurements. J. Pharm. Sci., 71, 7-13.
20. Parrot, E. L. (1981). Thermal hardness coefficient of tablets. J. Pharm. Sci., 70, 328-329.
21. Robinson, J. R., & McGinity, J. W. (2000). Effervescent granules and methods for their preparation, US Patent No. 6071539.
22. Rong-kun, C., Xiaodi, G., Beth, A. B., & Richard, A. C. (2000). Fast dissolving tablets. Pharm. Technol., 24, 52-56.
23. Seager, H. (1998). Drug-deliver products and the Zydis fast-dissolving dosage form. J. Pharm. Pharmacol., 50, 375-382.
24. Shah, R. D., Kabadi, M., Pope, D. G., & Augsburger, L. L. (1995). Physicomechanical characterization of the extrusion-spheronization process. II: Rheological determinants for successful extrusion and spheronization. Pharm. Res., 12, 496-507.
25. Smith, S. (1961). Stabilization of effervescent carbonate powders. US Patent No. 2984543.
26. Swarbrick, J., & Boylan, J. (2002). Encyclopedia of pharmaceutical technology (Vol. 1, pp. 1037-1049). New York: Marcel Dekker Inc.
27. The United States Pharmacopoeia-24/National Formulary-19. (2000). Asian Edition. Rockville, MD: US Pharmacopeial Convention Inc., 1942.
28. Train, D. (1958). Some aspects of the property of angle of repose of powders. J. Pharm. Pharmacol., 10(Suppl), 127T-135T.
29. Walid, H., Raj, K., & John, H. (2000). Fast dissolve drug delivery system. Crit. Rev. Ther. Drug Carrier Syst., 17, 61-73.
30. Wehling, F., Scheuhle, S., & Madamala, N. (1993). Effervescent dosage form with microparticles. US Patent No. 5178878.
31. Wells, M. L., Wood, D. L., Sanftlesen, R., Shaw, K., Hottouy, J., Weber, T., Geoffray, J. M., Alkaire, T. G., Emptage, M. R., & Sombia, R. (1997). Potassium carbonate as a desiccant in effervescent tablets. Int. J. Pharm., 152, 227-235.
32. Witzel, F., & Clark, K. W. (1978). Effervescent tablet and method. US Patent No. 4127645.